Startups
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.
Summary
29
Industry
Total funding Amount
$33M
Fundraising History
-
Jun 01 '22 Series A$32M
-
Nov 01 '21 Unknown$16M
-
Aug 01 '19 Unknown$1.5M
Investors
-
EIR VenturesUnknown